Volume | 932,400 |
|
|||||
News | - | ||||||
Day High | 1.02 | Low High |
|||||
Day Low | 0.95 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Assertio Holdings Inc | ASRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.01 | 0.95 | 1.02 | 0.9593 | 0.99 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
2,654 | 932,400 | US$ 0.9749687 | US$ 909,061 | - | 0.77 - 8.01 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:40:07 | 25 | US$ 1.00 | USD |
Assertio Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
91.2M | 95.00M | - | 156.23M | 109.63M | 1.15 | 0.83 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Assertio News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASRT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.05 | 1.09 | 0.95 | 1.01 | 1,136,632 | -0.08 | -7.62% |
1 Month | 0.8542 | 1.21 | 0.8401 | 1.02 | 1,450,090 | 0.1158 | 13.56% |
3 Months | 1.00 | 1.21 | 0.77 | 0.9440271 | 1,082,525 | -0.03 | -3.00% |
6 Months | 2.64 | 2.70 | 0.77 | 1.31 | 1,304,235 | -1.67 | -63.26% |
1 Year | 5.98 | 8.01 | 0.77 | 3.60 | 1,731,723 | -5.01 | -83.78% |
3 Years | 0.6941 | 8.01 | 0.419 | 2.77 | 1,566,104 | 0.2759 | 39.75% |
5 Years | 4.51 | 8.01 | 0.33 | 1.72 | 2,333,783 | -3.54 | -78.49% |
Assertio Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |